Embedded Files
The latest report by IMARC Group, titled “United States Biologics Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,“ offers a comprehensive analysis of the industry, which comprises insights into the United States biologics market share. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The United States biologics market size is projected to exhibit a growth rate (CAGR) of 7.12% during 2024-2032.
United States Biologics Market Overview:
Biologics are pharmaceutical products derived from living organisms or their components, including proteins, nucleic acids, and cells. Unlike traditional small-molecule drugs, which are chemically synthesized, biologics are typically produced through complex biological processes, such as recombinant DNA technology or cell culture. These products are used to treat a wide range of diseases and medical conditions, including cancer, autoimmune disorders, and infectious diseases. Biologics offer targeted therapies with high specificity and efficacy, often with fewer side effects compared to conventional treatments. They have revolutionized the treatment landscape, providing innovative and personalized treatment options for patients worldwide. As research in biotechnology continues to advance, the development and utilization of biologics are expected to play an increasingly prominent role in modern medicine.
Request to Get the Free Sample Report: https://www.imarcgroup.com/united-states-biologics-market/requestsample
United States Biologics Market Trends:
The market in the United States is majorly driven by changing demographic trends. Rising prevalence of chronic diseases such as cancer, autoimmune disorders, and diabetes, coupled with an aging population, is fueling demand for biologic therapies that offer targeted and personalized treatment options. Additionally, advancements in biotechnology and genetic engineering are driving the development of novel biologics with enhanced efficacy and reduced side effects, expanding the therapeutic options available to patients. Regulatory initiatives such as the Biologics Price Competition and Innovation Act (BPCIA) and the Orphan Drug Act provide incentives for biologic innovation and market entry, stimulating competition and fostering a conducive environment for market growth. Moreover, increasing healthcare expenditure, coupled with expanding insurance coverage and patient access programs, is driving uptake of biologic therapies across diverse patient populations. The ongoing COVID-19 pandemic has further underscored the importance of biologics in combating infectious diseases, accelerating research and development efforts in this area.
United States Biologics Market Segmentation:
Source Insights:
Microbial
Mammalian
Others
Product Insights:
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense, RNAi and Molecular Therapy
Others
Disease Insights:
Oncology
Immunological Disorders
Cardiovascular Disorders
Hematological Disorders
Others
Manufacturing Insights:
Outsourced
In-House
Regional Insights:
Northeast
Midwest
South
West
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
Market Performance (2018-2023)
Market Outlook (2024-2032)
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Strategic Recommendations
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Page updated
Google Sites
Report abuse